Warren Buffett Is Selling These 5 Stocks

In this article, we discuss the 5 stocks that Warren Buffett is selling. If you want to read our detailed analysis of these stocks, go directly to Warren Buffett Is Selling These 10 Stocks. 

5. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Hedge Fund Holders: 74

Percentage Decrease in Stake in Q4: 77%  

Bristol-Myers Squibb Company (NYSE:BMY) makes and sells biopharma products. Hedge funds are exceedingly bullish on the stock. At the end of the third quarter of 2021, 74 hedge funds in the database of Insider Monkey held stakes worth $4.5 billion in Bristol-Myers Squibb Company (NYSE:BMY). 

However, Berkshire has been busy selling Bristol-Myers Squibb Company (NYSE:BMY) stock in the past few months. The fund decreased its stake in the company by  staggering 77% in the fourth quarter of 2021. It now owns 5.2 million shares of Bristol-Myers Squibb Company (NYSE:BMY) worth $324 million, representing 0.09% of the portfolio. 

In its Q4 2020 investor letter, Wedgewood Partners, an asset management firm, highlighted a few stocks and Bristol-Myers Squibb Company (NYSE:BMY) was one of them. Here is what the fund said:

“Bristol-Myers Squibb recently reported accelerating sales as much of the medical services industry returned to work. The Company continues to expect double-digit earnings growth over the next few years, driven by existing drugs, in addition to a broad pipeline of new drugs and indications. While the market remains fixated on a couple of patent expirations that could occur over the next several years, we think this is well-known at this point, yet the market still undervalues a couple of key acquisitions the Company has made in the past few years, particularly Celgene, which was acquired for a song.”